Key result
Polio survivors had significantly lower mean plasma IGF-I concentrations compared to healthy controls (0.45 vs 0.60 units/mL, P < 0.01), which correlated with ADL dysfunction.
Why the study?
Do polio survivors have lower plasma IGF-I levels compared to healthy controls?
Cross-Sectional (n=385)
Do polio survivors have lower plasma IGF-I levels compared to healthy controls?
Polio survivors exhibit significantly lower plasma IGF-I levels than healthy controls, a finding that correlates with dysfunction in activities of daily living.
Should not change practice in polio survivors; leaves open IGF-I role in post-polio ADL dysfunction.
OBJECTIVE: To compare plasma levels of insulin-like growth factor-I (IGF-I, also termed somatomedin C) in polio survivors and healthy control subjects and to determine their relation to selected clinical characteristics. DESIGN: Cross sectional study. SETTING: Polio survivors living in the community recruited from the Wisconsin Polio Support Group. PARTICIPANTS: A total of 124 polio survivors (49 males and 75 females), ages 35 to 77 years, and 261 healthy control subjects (139 males and 122 females) of similar age. MEASUREMENTS: Plasma IGF-I levels were compared in polio survivors and age-matched control subjects. In the polio survivor group, the relation of IGF-I to selected clinical characteristics was examined before and after adjusting for covariates. RESULTS: Statistical analyses showed that the IGF-I concentrations were significantly lower in the polio survivors than in the controls. This difference was reflected in the means and standard errors of the two groups (0.45 +/- 0.02 vs 0.60 +/- 0.02 units/mL, P < 0.01). Plasma IGF-I below 0.35 units/mL in adults indicates little or no growth hormone secretion. In polio survivors, 38% of the plasma IGF-I values were < 0.35 units/mL compared with 19% in the healthy group. Univariate analysis showed that IGF-I in the polio survivors was significantly correlated with age, gender, and body mass index, and with dependency, pain, and difficulty in the activities of daily living (ADLs). The correlations with ADL dysfunction were independent of the correlations with age, gender, and body mass index. IGF-I level did not correlate with the subjective report of recent decline in functional status. CONCLUSION: Lower levels of IGF-I are seen in polio survivors, and this finding correlates with ADL dysfunction. The hyposomatomedinemic tendency of polio survivors may have an adverse effect on their neuromuscular function and quality of life.
No takes yet. Share an insight, caveat, or question.
Rao et al. (1993) conducted a cross-sectional in Poliomyelitis (n=385). History of poliomyelitis vs. Healthy control subjects was evaluated on Plasma IGF-I levels (units/mL) (p=< 0.01). Polio survivors had significantly lower mean plasma IGF-I concentrations compared to healthy controls (0.45 vs 0.60 units/mL, P < 0.01), which correlated with ADL dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: